Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 27, 2025World Journal of HepatologyOpen Access

Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease

View Full Paper
Ask AI
Bookmark
Share

Authors

SRSantiago RodríguezUniversidade Federal de Ciências da Saúde de Porto AlegreMDMaria Luiza Fernandes DahlemUniversidade Federal do Rio Grande do SulCRCarina RossoniUniversity of Lisbon

Discussion

Loading...

Member takes

Overview

Review highlights dietary epigenetic modulation's role in metabolic dysfunction and steatotic liver disease.

Key Points

  • Epigenetic regulation plays a crucial role in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD), linking diet and disease development.
  • Key mechanisms include DNA methylation and histone modification, which regulate gene expression without altering the DNA sequence itself.
  • The impact of MASLD extends beyond liver health, affecting patients and healthcare systems significantly.
  • Diet, particularly the Westernized diet, is implicated in the pathogenesis of MASLD through various epigenetic pathways.

Cite This Study

Rodríguez et al. (2025) studied this question.

synapsesocial.com/papers/68af63efad7bf08b1eae4c17https://doi.org/10.4254/wjh.v17.i8.108182
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sirt1-PPARS Cross-Talk in Complex Metabolic Diseases and Inherited Disorders of the One Carbon Metabolism2020 · 71 citations
  2. 2Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases2024 · 95 citations
  3. 3Alterations in the hepatocyte epigenetic landscape in steatosis2023 · 5 citations
  4. 4Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents2016 · 277 citations